brl-28500 and Connective-Tissue-Diseases

brl-28500 has been researched along with Connective-Tissue-Diseases* in 2 studies

Other Studies

2 other study(ies) available for brl-28500 and Connective-Tissue-Diseases

ArticleYear
[Combinations of beta-lactamase inhibitors and semisynthetic penicillins: amoxycillin/clavulanic acid (augmentin, amox-clav ), thycarcillin/clavulanic acid (thymentin). Action and usage].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1997, Volume: 42, Issue:12

    Topics: Amoxicillin-Potassium Clavulanate Combination; beta-Lactamase Inhibitors; Clavulanic Acids; Connective Tissue Diseases; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Skin Diseases, Bacterial; Ticarcillin; Urinary Tract Infections

1997
The effect of timentin in the treatment of female pelvic soft tissue infections.
    Pharmacotherapy, 1991, Volume: 11, Issue:2 ( Pt 2)

    Ticarcillin plus clavulanic acid (Timentin) has a broad-spectrum activity that includes gram-positive aerobes, and facultative and obligate anaerobes. Numerous studies have demonstrated that single agents, including this combination, are as efficacious as clindamycin plus an aminoglycoside in treating gynecologic soft tissue infections. Its spectrum of activity, together with its potential for treating Chlamydia trachomatis, makes it suitable for the treatment of pelvic inflammatory disease.

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acids; Connective Tissue Diseases; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Pelvic Inflammatory Disease; Ticarcillin; Vagina

1991